Cargando…
Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders
Protein phosphatases act as key regulators of multiple important cellular processes and are attractive therapeutic targets for various diseases. Although extensive effort has been dedicated to phosphatase-targeted drug discovery, early expeditions for competitive phosphatase inhibitors were plagued...
Autores principales: | Stanford, Stephanie M., Bottini, Nunzio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872771/ https://www.ncbi.nlm.nih.gov/pubmed/36693907 http://dx.doi.org/10.1038/s41573-022-00618-w |
Ejemplares similares
-
Autoimmunity linked protein phosphatase PTPN22 as a target for cancer immunotherapy
por: Cubas, Rafael, et al.
Publicado: (2020) -
Macromolecular crowding amplifies allosteric regulation of T-cell protein tyrosine phosphatase
por: Tun, May Thwe, et al.
Publicado: (2022) -
PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis
por: Hsieh, Wan-Chen, et al.
Publicado: (2020) -
Inflammatory Bowel Disease: Are There Gender Differences in the Genetics of Signal Transduction? A Preliminary Study of Cytosolic Low Molecular Weight Protein Tyrosine Phosphatase
por: Bottini, Nunzio, et al.
Publicado: (2000) -
Phosphotyrosine-Protein-Phosphatase and Diabetic Disorders. Further Studies on the Relationship between Low Molecular Weight Acid Phosphatase Genotype and Degree of Glycemic Control
por: Lucarini, N., et al.
Publicado: (1998)